Steris Plc’s recent filing unveils that its Sr. VP, Gen Counsel, and Sec. Zangerle John Adam unloaded Company’s shares for reported $3.98 million on Nov 11 ’25. In the deal valued at $265.14 per share,15,000 shares were sold. As a result of this transaction, Zangerle John Adam now holds 33,669 shares worth roughly $8.7 million.
Then, Zangerle John Adam bought 15,000 shares, generating $3,977,050 in total proceeds.
Before that, Carestio Daniel A sold 159 shares. Steris Plc shares valued at $38,449 were divested by the President and CEO at a price of $241.82 per share. As a result of the transaction, Carestio Daniel A now holds 51,096 shares, worth roughly $13.2 million.
Morgan Stanley upgraded its Steris Plc [STE] rating to an Overweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late May with a ‘”a Hold”‘ rating. Piper Sandler also remained covering STE and has increased its forecast on October 24, 2024 with a “an Overweight” recommendation from previously “Neutral” rating.
Price Performance Review of STE
On Friday, Steris Plc [NYSE:STE] saw its stock fall -0.78% to $258.41. Over the last five days, the stock has lost -2.03%. Steris Plc shares have risen nearly 16.02% since the year began. Nevertheless, the stocks have risen 25.71% over the past one year. While a 52-week high of $268.30 was reached on 11/12/25, a 52-week low of $200.98 was recorded on 01/03/25.
Levels Of Support And Resistance For STE Stock
The 24-hour chart illustrates a support level at 256.40, which if violated will result in even more drops to 254.38. On the upside, there is a resistance level at 260.74. A further resistance level may holdings at 263.07.
How much short interest is there in Steris Plc?
A steep rise in short interest was recorded in Steris Plc stocks on 2025-10-31, dropping by -0.16 million shares to a total of 0.96 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 1.12 million shares. There was a decline of -17.14%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 30, 2023 when Morgan Stanley began covering the stock and recommended ‘”an Equal-weight”‘ rating along with a $206 price target.
